Wellcome Sanger Institute, Hinxton, CB10 1SA, UK.
Department of Paediatrics, University of Cambridge, Cambridge, CB2 0QQ, UK.
Nat Commun. 2023 Sep 25;14(1):5826. doi: 10.1038/s41467-023-41118-8.
Reninomas are exceedingly rare renin-secreting kidney tumours that derive from juxtaglomerular cells, specialised smooth muscle cells that reside at the vascular inlet of glomeruli. They are the central component of the juxtaglomerular apparatus which controls systemic blood pressure through the secretion of renin. We assess somatic changes in reninoma and find structural variants that generate canonical activating rearrangements of, NOTCH1 whilst removing its negative regulator, NRARP. Accordingly, in single reninoma nuclei we observe excessive renin and NOTCH1 signalling mRNAs, with a concomitant non-excess of NRARP expression. Re-analysis of previously published reninoma bulk transcriptomes further corroborates our observation of dysregulated Notch pathway signalling in reninoma. Our findings reveal NOTCH1 rearrangements in reninoma, therapeutically targetable through existing NOTCH1 inhibitors, and indicate that unscheduled Notch signalling may be a disease-defining feature of reninoma.
肾素瘤是极为罕见的分泌肾素的肾脏肿瘤,来源于肾小球旁细胞,即位于肾小球血管入口处的特殊平滑肌细胞。它们是肾小球旁器的核心组成部分,通过分泌肾素来控制全身血压。我们评估了肾素瘤中的体细胞变化,并发现了结构变异,这些变异产生了 Notch1 的经典激活重排,同时去除了其负调节剂 NRARP。因此,在单个肾素瘤细胞核中,我们观察到过量的肾素和 Notch1 信号 mRNA,同时 NRARP 的表达并不过量。对先前发表的肾素瘤批量转录组的重新分析进一步证实了我们在肾素瘤中观察到的 Notch 通路信号失调。我们的发现揭示了肾素瘤中的 Notch1 重排,可通过现有的 Notch1 抑制剂进行治疗,这表明未调节的 Notch 信号可能是肾素瘤的疾病定义特征。